Fundraising FoxInvictus Therapeutics
1 known investors
Find your way into Invictus Therapeutics
Sign up to see every warm intro you have to Invictus Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Invictus Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Invictus Therapeutics develops novel insulin analogs and related pump technologies aimed at insulin-dependent diabetic patients, focusing on ultra-rapid, concentrated, room-temperature-stable insulin for next-generation insulin pumps. Its lead candidate is a monomeric insulin formulation with improved pharmacokinetics and extended stability.
Founders & leadership
MW
Michel WeissMD, PhD, MBA
Investors · 1
Frequently asked questions
- What does Invictus Therapeutics do?
- Invictus Therapeutics develops novel insulin analogs and related pump technologies aimed at insulin-dependent diabetic patients, focusing on ultra-rapid, concentrated, room-temperature-stable insulin for next-generation insulin pumps. Its lead candidate is a monomeric insulin formulation with improved pharmacokinetics and extended stability.
- Who are Invictus Therapeutics's investors?
- Invictus Therapeutics's investors include CWRU Technology Ventures.